20 results on '"De Lena M"'
Search Results
2. Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
3. Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: A Southern Italy Cooperative Oncology Group phase II–III randomized trial
4. Adjuvant hormonetherapy for slow proliferating node-negative breast cancer patients. Results of the phase III trial of NCl-Bari
5. Adjuvant polychemotherapy vs control for node-negative, rapidly proliferating breast cancer: Combined analysis of two phase III trials
6. Taxol, gemcitabine and vinorelbine, a very active platinum free triplet in naive patients with Non Small Cell Lung Cancer
7. Taxol-gemcitabine-vinorelbine (TGV) given every 2 weeks in chemo-naive advanced NSCLC. A SICOG phase I study
8. Oxaliplatin (L-OHP) and irinotecan (CPT-11) with 6s-leucovorin (IFA)-modulated 5-fluorouracil (FU) i.v. bolus every 2 weeks: a dose-finding study in patients (pts) with gastrointestinal malignancies
9. Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): a phase II multicenter trial
10. Phase I/II study of gemcitabine plus mitoxantrone in advanced breast cancer (ABC)
11. Gemcitabine + vinorelbine (GV) vs vinorelbine (V) alone in elderly or frail non-small cell lung cancer (NSCLC) patients. Interim analysis of a SICOG phase III trial
12. Simultaneous determination of 5′-deoxy-5-fluorouridine, 5-fluorouracil and 5,6-dihydro-5-fluorouracil in serum by liquid chromatography with diode array UV detection
13. Heterogeneity of intratumour proliferative activity in primary breast cancer: Biological and clinical aspects
14. A shared effort toward better quality of care. The Consensus Conference on Breast Cancer Follow-up
15. Subcutaneous recombinant interleukin-2 plus chemotherapy with cisplatin and dacarbazine in metastatic melanoma
16. Hormone receptor modulation by a sequential alternate TAM/MPA administration monitored by drugs plasma level
17. 1147 Gemcitabine in resistant stage IV bladder cancer: A phase II study
18. Phase I study of carboplatin, epirubicin and VP-16 plus G-CSF in extensive small cell lung cancer (SCLC)
19. Clinical-biological characterization of second neoplasm patients
20. Peripheral hemato-immunological modifications induced by subcutaneous (SC) rIL-2 treatment of advanced neoplasms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.